A critical and comprehensive look at current state-of-the-art scientific and translational
research being conducted internationally in academia and industry to address new ways to
provide effective treatment to victims of ischemic and hemorrhagic stroke and other ischemic
diseases. Currently stroke can be successfully treated through the administration of a
thrombolytic but the therapeutic window is short and many patients are not able to receive
treatment. Only about 30% of patients are cured by available treatments. In 5 sections the
proposed volume will explore historical and novel neuroprotection mechanisms and targets new
and combination therapies as well as clinical trial design for some of the recent bench-side
research.
